GRANT PICKERING - 04 Apr 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
04 Apr 2025
Net transactions value
+$183,888
Form type
4
Filing time
07 Apr 2025, 07:38:05 UTC
Previous filing
03 Mar 2025
Next filing
03 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $84,428 +15,781 +3.2% $5.35 514,023 04 Apr 2025 Direct
transaction PCVX Common Stock Options Exercise $99,459 +4,752 +0.92% $20.93 518,775 04 Apr 2025 Direct
holding PCVX Common Stock 136,215 04 Apr 2025 By Children's Trust F1
holding PCVX Common Stock 136,215 04 Apr 2025 By Children's Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -15,781 -7.8% $0.000000 186,936 04 Apr 2025 Common Stock 15,781 $5.35 Direct F3
transaction PCVX Stock Option (right to buy) Options Exercise $0 -4,752 -1.6% $0.000000 298,360 04 Apr 2025 Common Stock 4,752 $20.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F2 Shares are held directly by a trust for the benefit of the Reporting Person's son.
F3 Stock Option is fully vested and exercisable.